CN118286096A - Freckle-removing and whitening essence and preparation method thereof - Google Patents
Freckle-removing and whitening essence and preparation method thereof Download PDFInfo
- Publication number
- CN118286096A CN118286096A CN202410402420.6A CN202410402420A CN118286096A CN 118286096 A CN118286096 A CN 118286096A CN 202410402420 A CN202410402420 A CN 202410402420A CN 118286096 A CN118286096 A CN 118286096A
- Authority
- CN
- China
- Prior art keywords
- parts
- lightening
- spot
- complex
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 95
- 230000002087 whitening effect Effects 0.000 title claims abstract description 57
- 208000003351 Melanosis Diseases 0.000 title claims description 6
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims abstract description 41
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 claims abstract description 35
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims abstract description 34
- 229920002079 Ellagic acid Polymers 0.000 claims abstract description 34
- 102000007625 Hirudins Human genes 0.000 claims abstract description 34
- 108010007267 Hirudins Proteins 0.000 claims abstract description 34
- 229960002852 ellagic acid Drugs 0.000 claims abstract description 34
- 235000004132 ellagic acid Nutrition 0.000 claims abstract description 34
- 229940006607 hirudin Drugs 0.000 claims abstract description 34
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000419 plant extract Substances 0.000 claims abstract description 34
- -1 ellagic acid chelate complex Chemical class 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- NMHMNPHRMNGLLB-UHFFFAOYSA-N p-hydroxybenzene propanoic acid Natural products OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002131 composite material Substances 0.000 claims abstract description 13
- 239000008367 deionised water Substances 0.000 claims abstract description 9
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 8
- 239000003974 emollient agent Substances 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 239000003906 humectant Substances 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 50
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 49
- 239000000686 essence Substances 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 27
- 102000004190 Enzymes Human genes 0.000 claims description 25
- 108090000790 Enzymes Proteins 0.000 claims description 25
- 229940088598 enzyme Drugs 0.000 claims description 25
- 230000005496 eutectics Effects 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 21
- 150000004676 glycans Chemical class 0.000 claims description 20
- 239000012071 phase Substances 0.000 claims description 20
- 229920001282 polysaccharide Polymers 0.000 claims description 20
- 239000005017 polysaccharide Substances 0.000 claims description 20
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 19
- 239000006166 lysate Substances 0.000 claims description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- 238000000855 fermentation Methods 0.000 claims description 18
- 230000004151 fermentation Effects 0.000 claims description 18
- 230000001580 bacterial effect Effects 0.000 claims description 17
- 239000003755 preservative agent Substances 0.000 claims description 17
- 230000002335 preservative effect Effects 0.000 claims description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 15
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 15
- 229930003935 flavonoid Natural products 0.000 claims description 15
- 150000002215 flavonoids Chemical class 0.000 claims description 15
- 235000017173 flavonoids Nutrition 0.000 claims description 15
- 229930182490 saponin Natural products 0.000 claims description 15
- 150000007949 saponins Chemical class 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 14
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000011812 mixed powder Substances 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 241001608472 Bifidobacterium longum Species 0.000 claims description 11
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 11
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 11
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 235000018185 Betula X alpestris Nutrition 0.000 claims description 10
- 235000018212 Betula X uliginosa Nutrition 0.000 claims description 10
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 9
- 239000001263 FEMA 3042 Substances 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 9
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims description 9
- 244000141353 Prunus domestica Species 0.000 claims description 9
- 235000011435 Prunus domestica Nutrition 0.000 claims description 9
- 229930003268 Vitamin C Natural products 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 235000015523 tannic acid Nutrition 0.000 claims description 9
- 229920002258 tannic acid Polymers 0.000 claims description 9
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims description 9
- 229940033123 tannic acid Drugs 0.000 claims description 9
- 235000019154 vitamin C Nutrition 0.000 claims description 9
- 239000011718 vitamin C Substances 0.000 claims description 9
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000012074 organic phase Substances 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 108010059892 Cellulase Proteins 0.000 claims description 7
- 108010059820 Polygalacturonase Proteins 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 7
- 229940106157 cellulase Drugs 0.000 claims description 7
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 7
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 7
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 7
- 235000019165 vitamin E Nutrition 0.000 claims description 7
- 229940046009 vitamin E Drugs 0.000 claims description 7
- 239000011709 vitamin E Substances 0.000 claims description 7
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims description 6
- 241000186000 Bifidobacterium Species 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical class 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 235000019743 Choline chloride Nutrition 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 5
- 229960003178 choline chloride Drugs 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 239000012046 mixed solvent Substances 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 230000000717 retained effect Effects 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 229920002125 Sokalan® Polymers 0.000 claims description 3
- 229960001631 carbomer Drugs 0.000 claims description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 3
- 229940075529 glyceryl stearate Drugs 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 3
- 229920000058 polyacrylate Polymers 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 229940051250 hexylene glycol Drugs 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 2
- 229960004063 propylene glycol Drugs 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229940104261 taurate Drugs 0.000 claims description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 2
- 229940074410 trehalose Drugs 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 claims 1
- 241000144217 Limnanthes alba Species 0.000 claims 1
- 229940008099 dimethicone Drugs 0.000 claims 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 2
- 230000037394 skin elasticity Effects 0.000 abstract description 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 58
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 28
- 210000003491 skin Anatomy 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 13
- 235000017709 saponins Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 230000006872 improvement Effects 0.000 description 9
- 241000736199 Paeonia Species 0.000 description 7
- 241000125175 Angelica Species 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 230000036564 melanin content Effects 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- SFMJNHNUOVADRW-UHFFFAOYSA-N n-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Chemical compound C1=C(NC(=O)C=C)C(C)=CC=C1N1C(=O)C=CC2=C1C1=CC(C=3C=CC(NS(C)(=O)=O)=CC=3)=CC=C1N=C2 SFMJNHNUOVADRW-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000000413 hydrolysate Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 2
- 101710200814 Melanotropin alpha Proteins 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 108010087230 Sincalide Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000001180 angelica archangelica l. root extract Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 1
- 230000002910 effect on acne Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- HEILIGJNYTWOHU-UHFFFAOYSA-N ethanol 2-hydroxybenzoic acid Chemical compound CCO.OC(=O)C1=CC=CC=C1O HEILIGJNYTWOHU-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域Technical Field
本发明涉及化妆品技术领域,具体涉及一种淡斑美白精华液及其制备方法。The invention relates to the technical field of cosmetics, and in particular to a spot-lightening and whitening essence and a preparation method thereof.
背景技术Background technique
随着人民生活水平和审美标准的提高,白皙与洁润的肌肤越来越被大多数女性所推崇。一直以来,美白淡斑都是人们所热切关注的话题。人们希望通过美白护理品的使用而得到白皙、光洁透亮的皮肤,更有一些利用功能型美白化妆品来减轻色斑沉积。紫外线、污染的空气、活性氧等环境因素,会加速皮肤中黑色素的生成,使皮肤老化加快,皮肤松弛,色斑沉着,肤色暗黄,没有光泽并且出现各种细纹,皱纹。With the improvement of people's living standards and aesthetic standards, fair and clean skin is increasingly admired by most women. Whitening and lightening of spots have always been a topic of keen concern. People hope to get fair, smooth and translucent skin through the use of whitening care products, and some use functional whitening cosmetics to reduce the deposition of spots. Environmental factors such as ultraviolet rays, polluted air, and active oxygen will accelerate the production of melanin in the skin, accelerate skin aging, loose skin, pigmentation, dark yellow skin color, lack of luster, and various fine lines and wrinkles.
市面上美白活性成分很多,但都有一定的缺点。第一,一些美白活性成分会导致皮肤出现刺激、过敏等现象;第二,多数美白活性成分不稳定,易氧化变质、变色而失去美白作用;第三,有些美白活性成分的表皮渗透性差,难以透过角质层进入皮肤基底层发挥作用。第四,通过抑制酪氨酸酶的活性来减少黑色素的生成,或是通过将已生成的黑色素分解代谢、还原,达到美白淡斑的效果,采用的活性成分主要是熊果苷、抗坏血酸磷酸酯钠(维生素C)、曲酸棕榈酸酯等合成化学制剂,作用效果有限,易反弹。There are many whitening active ingredients on the market, but they all have certain disadvantages. First, some whitening active ingredients can cause skin irritation, allergies and other phenomena; second, most whitening active ingredients are unstable and easily oxidized, deteriorated, discolored and lose their whitening effects; third, some whitening active ingredients have poor epidermal permeability and are difficult to penetrate the stratum corneum into the basal layer of the skin to exert their effects. Fourth, the whitening and spot-removing effects are achieved by inhibiting the activity of tyrosinase to reduce the production of melanin, or by decomposing and reducing the melanin that has been produced. The active ingredients used are mainly synthetic chemical preparations such as arbutin, sodium ascorbyl phosphate (vitamin C), and kojic acid palmitate, which have limited effects and are prone to rebound.
发明内容Summary of the invention
本发明的目的在于提出一种淡斑美白精华液及其制备方法,具有较好的美白、淡斑、紧致皮肤、抗氧化、抗炎、保湿、提高皮肤弹性、延缓衰老的效果,且原料来源广,制备方法简单,具有广阔的应用前景。The purpose of the present invention is to provide a whitening and freckle removal essence and a preparation method thereof, which has good whitening, freckle removal, skin tightening, anti-oxidation, anti-inflammatory, moisturizing, improving skin elasticity, and anti-aging effects, and has a wide source of raw materials, a simple preparation method, and broad application prospects.
本发明的技术方案是这样实现的:The technical solution of the present invention is achieved in this way:
本发明提供一种淡斑美白精华液,由以下原料按重量份制备而成:植物提取物10-20份、水蛭素/根皮素/鞣花酸螯合复合物3-5份、润肤剂10-20份、保湿剂5-10份、增稠剂0.3-1份、乳化剂0.5-3份、去离子水40-60份。The invention provides a spot-lightening and whitening essence, which is prepared from the following raw materials by weight: 10-20 parts of plant extract, 3-5 parts of hirudin/phloretin/ellagic acid chelate complex, 10-20 parts of emollient, 5-10 parts of humectant, 0.3-1 parts of thickener, 0.5-3 parts of emulsifier and 40-60 parts of deionized water.
作为本发明的进一步改进,所述植物提取物的制备方法包括以下步骤:As a further improvement of the present invention, the method for preparing the plant extract comprises the following steps:
S1.深共熔溶剂中酶解:将白桦树皮、珠丝毛蓝耳草根、欧洲李、牡丹根、当归根分别洗净,干燥,粉碎,制得混合粉,加入含有深共熔溶剂的水溶液中,加入复合酶,酶解,灭酶,制得酶解产物;S1. Enzymatic hydrolysis in a deep eutectic solvent: washing, drying, and crushing birch bark, root of blue ear grass, European plum, peony root, and angelica root respectively to obtain a mixed powder, adding the mixed powder to an aqueous solution containing a deep eutectic solvent, adding a composite enzyme, performing enzymatic hydrolysis, and inactivating the enzyme to obtain an enzymatic hydrolysis product;
S2.发酵:将步骤S1中的酶解产物灭菌,接种长双歧杆菌、婴儿双歧杆菌菌种种子液,发酵培养,过滤,固体洗涤,收集洗脱液浓缩得到菌液,滤液留用;S2 fermentation: the enzymatic product of step S1 is sterilized, inoculated with Bifidobacterium longum, Bifidobacterium infantis seed solution, fermented, filtered, washed with solids, the eluate is collected and concentrated to obtain a bacterial solution, and the filtrate is retained;
S3.二裂酵母溶胞物的制备:将步骤S2制得的菌液液氮冷冻,室温溶解,离心,收集上清液,冷冻干燥,制得二裂酵母溶胞物;S3. Preparation of bifid yeast lysate: The bacterial solution obtained in step S2 was frozen in liquid nitrogen, dissolved at room temperature, centrifuged, the supernatant was collected, and freeze-dried to obtain bifid yeast lysate;
S4.多糖组合物的制备:向步骤S2制得的滤液中加入乙醇沉淀,离心,收集固体,上清液回收乙醇,得到的溶液留用,固体洗涤,干燥,制得多糖组合物;S4. Preparation of a polysaccharide composition: adding ethanol to the filtrate obtained in step S2 for precipitation, centrifuging, collecting the solid, recovering ethanol from the supernatant, retaining the obtained solution, washing the solid, and drying to obtain a polysaccharide composition;
S5.分离纯化:将有机溶剂加入步骤S3中的溶液中,萃取,收集有机相,大孔树脂分离纯化,获得黄酮/皂苷复合物;S5. Separation and purification: adding an organic solvent to the solution in step S3, extracting, collecting the organic phase, separating and purifying with a macroporous resin to obtain a flavonoid/saponin complex;
S6.保鲜剂的制备:将维生素C和维生素E混合均匀,制得保鲜剂;S6. Preparation of preservative: Mixing vitamin C and vitamin E to obtain a preservative;
S7.植物提取物的制备:将步骤S3制得的二裂酵母溶胞物、步骤S4制得的多糖组合物、步骤S5制得的黄酮/皂苷复合物、步骤S6制得的保鲜剂混合均匀,制得植物提取物。S7. Preparation of plant extract: uniformly mix the bifid yeast lysate obtained in step S3, the polysaccharide composition obtained in step S4, the flavonoid/saponin complex obtained in step S5, and the preservative obtained in step S6 to obtain a plant extract.
作为本发明的进一步改进,步骤S1中所述白桦树皮、珠丝毛蓝耳草根、欧洲李、牡丹根、当归根的质量比为3-5:1-3:7-12:3-5:1-2,所述混合粉和含有深共熔溶剂的水溶液的质量比为1:5-7,所述复合酶由纤维素酶和果胶酶混合组成,质量比为10-15:3-5,所述复合酶的添加量为体系总质量的2-3wt%,所述含有深共熔溶剂的水溶液中水的含量为40-60wt%,所述深共熔溶剂由氯化胆碱和葡萄糖按照摩尔比1:1混合制备而成,所述酶解的温度为40-50℃,时间为1-3h;步骤S2中所述长双歧杆菌、婴儿双歧杆菌菌种种子液的接种量分别为1-2v/v%和2-4v/v%,所述菌种种子液的含菌量为108-109cfu/mL,所述发酵培养的条件为无氧条件下,36-39℃,150-200r/min,发酵培养24-48h。As a further improvement of the present invention, the mass ratio of birch bark, pearl silk blue ear grass root, European plum, peony root, and angelica root in step S1 is 3-5:1-3:7-12:3-5:1-2, the mass ratio of the mixed powder and the aqueous solution containing a deep eutectic solvent is 1:5-7, the composite enzyme is composed of a mixture of cellulase and pectinase, the mass ratio is 10-15:3-5, the addition amount of the composite enzyme is 2-3wt% of the total mass of the system, the water content in the aqueous solution containing a deep eutectic solvent is 40-60wt%, the deep eutectic solvent is prepared by mixing choline chloride and glucose in a molar ratio of 1:1, the temperature of the enzymolysis is 40-50°C, and the time is 1-3h; the inoculation amounts of the long bifidobacterium and infant bifidobacterium seed solutions in step S2 are 1-2v/v% and 2-4v/v%, respectively, and the bacterial content of the seed solution is 10 8 -10 9 cfu/mL, and the fermentation culture conditions are anaerobic conditions, 36-39°C, 150-200r/min, and the fermentation culture is 24-48h.
作为本发明的进一步改进,步骤S4中所述加入乙醇至体系中乙醇含量为60-80wt%,所述沉淀的时间为3-5h;步骤S5中所述所述有机溶剂和溶液的质量比为1-3:2-4,所述有机溶剂为二氯甲烷和四氢呋喃的混合溶剂,体积比为3-5:1,所述大孔树脂选自XDA-2、NKA-9、SP-825、D101、HPD600、X-5、LSA-10、NKI-9和AB-8中的至少一种。As a further improvement of the present invention, the ethanol content in the system added in step S4 is 60-80wt%, and the precipitation time is 3-5h; the mass ratio of the organic solvent and the solution in step S5 is 1-3:2-4, the organic solvent is a mixed solvent of dichloromethane and tetrahydrofuran, and the volume ratio is 3-5:1, and the macroporous resin is selected from at least one of XDA-2, NKA-9, SP-825, D101, HPD600, X-5, LSA-10, NKI-9 and AB-8.
作为本发明的进一步改进,步骤S6中所述维生素C和维生素E的质量比为10-15:3-7;步骤S7中所述二裂酵母溶胞物、多糖组合物、黄酮/皂苷复合物、保鲜剂的质量比为10-12:15-22:17-20:2-4。As a further improvement of the present invention, the mass ratio of vitamin C and vitamin E in step S6 is 10-15:3-7; the mass ratio of bifida yeast lysate, polysaccharide composition, flavonoid/saponin complex and preservative in step S7 is 10-12:15-22:17-20:2-4.
作为本发明的进一步改进,所述水蛭素/根皮素/鞣花酸螯合复合物的制备方法如下:As a further improvement of the present invention, the preparation method of the hirudin/phloretin/ellagic acid chelate complex is as follows:
T1.将水蛭素、根皮素、鞣花酸加入水中,加入三羟甲基氨基甲烷和单宁酸,调节溶液pH值,加热搅拌反应,制得复合物;T1. Add hirudin, phloretin, and ellagic acid to water, add tris(hydroxymethyl)aminomethane and tannic acid, adjust the pH value of the solution, heat and stir the reaction to obtain a complex;
T2.将步骤T1制得的复合物加入水中,加入硝酸银,搅拌反应,透析,干燥,制得水蛭素/根皮素/鞣花酸螯合复合物。T2. Add the complex prepared in step T1 into water, add silver nitrate, stir to react, dialyze, and dry to obtain a hirudin/phloretin/ellagic acid chelate complex.
作为本发明的进一步改进,步骤T1中所述水蛭素、根皮素、鞣花酸、三羟甲基氨基甲烷和单宁酸的质量比为12-15:3-5:2-4:2-4:5-7,所述调节溶液pH值为8.2-8.7,所述加热搅拌反应的温度为40-50℃,时间为1-3h;步骤T2中所述复合物、水和硝酸银的质量比为10-15:100:0.2-0.5,所述搅拌反应的时间为20-30min。As a further improvement of the present invention, the mass ratio of hirudin, phloretin, ellagic acid, tris(hydroxymethyl)aminomethane) and tannic acid in step T1 is 12-15:3-5:2-4:2-4:5-7, the pH value of the adjusted solution is 8.2-8.7, the temperature of the heated and stirred reaction is 40-50°C, and the time is 1-3h; the mass ratio of the complex, water and silver nitrate in step T2 is 10-15:100:0.2-0.5, and the stirring reaction time is 20-30min.
作为本发明的进一步改进,所述润肤剂选自甘油三(乙基己酸)酯、异壬酸异壬酯、聚二甲基硅氧烷、辛酸/癸酸甘油三酯、牛油果树(BUTYROSPERMUM PARKII)果脂、白池花(LIMNANTHES ALBA)籽油中的至少一种;所述保湿剂选自甘油、丁二醇、丙二醇、己二醇、透明质酸钠、甜菜碱、海藻糖、1,2-戊二醇中的至少一种;所述乳化剂选自甘油硬脂酸酯、PEG-100硬脂酸酯、鲸蜡硬脂醇橄榄油酸酯、山梨坦橄榄油酸酯、C12-20烷基葡糖苷、聚甘油-2硬脂酸酯中的至少一种;所述增稠剂选自卡波姆、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、聚丙烯酰基二甲基牛磺酸钠、聚丙烯酸酯交联聚合物-6、黄原胶中的至少一种。As a further improvement of the present invention, the emollient is selected from at least one of tri(ethylhexanoin)glyceryl, isononyl isononanoate, polydimethylsiloxane, caprylic/capric triglyceride, butyrospermum parkii fruit fat, and liminanthes alba seed oil; the moisturizer is selected from at least one of glycerol, butylene glycol, propylene glycol, hexylene glycol, sodium hyaluronate, betaine, trehalose, and 1,2-pentanediol; the emulsifier is selected from at least one of glyceryl stearate, PEG-100 stearate, cetearyl olive oil ester, sorbitan olive oil ester, C12-20 alkyl glucoside, and polyglyceryl-2 stearate; the thickener is selected from at least one of carbomer, acrylic acid (ester)/C10-30 alkyl acrylate crosspolymer, sodium polyacryloyldimethyl taurate, polyacrylate crosspolymer-6, and xanthan gum.
本发明进一步提供一种上述的淡斑美白精华液的制备方法,包括以下步骤:The present invention further provides a method for preparing the above-mentioned spot-lightening and whitening essence, comprising the following steps:
(1)将保湿剂、增稠剂加入去离子水中,加热至70-80℃,300-500r/min搅拌10-20min,制得A相;(1) Add a moisturizer and a thickener to deionized water, heat to 70-80° C., and stir at 300-500 r/min for 10-20 min to prepare phase A;
(2)将润肤剂、乳化剂、水蛭素/根皮素/鞣花酸螯合复合物混合,加热至70-80℃,300-500r/min搅拌10-20min,制得B相;(2) mixing the emollient, emulsifier, and hirudin/phloretin/ellagic acid chelate complex, heating to 70-80° C., and stirring at 300-500 r/min for 10-20 min to prepare phase B;
(3)将B相加入A相中,300-500r/min搅拌5-15min,7000-10000r/min乳化10-20min,保温10-20min,降温;(3) Add phase B to phase A, stir at 300-500 r/min for 5-15 min, emulsify at 7000-10000 r/min for 10-20 min, keep warm for 10-20 min, and cool down;
(4)降温至35-40℃后,加入植物提取物,300-500r/min搅拌5-15min,过滤,制得淡斑美白精华液。(4) After cooling to 35-40°C, add the plant extract, stir at 300-500 r/min for 5-15 min, filter, and obtain the spot-lightening and whitening essence.
本发明进一步提供一种上述的淡斑美白精华液在皮肤美白、淡斑、保湿中的应用。The present invention further provides a use of the above-mentioned spot-lightening and whitening essence in skin whitening, spot-lightening and moisturizing.
本发明具有如下有益效果:The present invention has the following beneficial effects:
本发明植物提取物以白桦树皮、珠丝毛蓝耳草根、欧洲李、牡丹根、当归根为原料,以酶为催化剂水解植物细胞壁,促进有效成分从胞内向提取介质中扩散,解决了传统提取工艺存在工序复杂、效率低下、提取质量差等缺点,但是,生物酶对水难溶性组分的提取效率差,本发明以深共熔溶剂为反应介质,大大提高难溶于水的化合物的提取,同时具有低毒绿色、动态可调、不可燃性和对化合物的强溶解度等诸多优点。本发明深共熔溶剂中以葡萄糖为原料之一,为后续进行发酵也提供了碳源。The plant extract of the present invention uses birch bark, pearl silk blue ear grass root, European plum, peony root, and angelica root as raw materials, uses enzymes as catalysts to hydrolyze plant cell walls, promotes the diffusion of effective ingredients from the cell to the extraction medium, and solves the shortcomings of traditional extraction processes such as complex procedures, low efficiency, and poor extraction quality. However, the extraction efficiency of biological enzymes for water-insoluble components is poor. The present invention uses deep eutectic solvents as reaction media, greatly improving the extraction of water-insoluble compounds, and has many advantages such as low toxicity, green, dynamically adjustable, non-flammable, and strong solubility for compounds. Glucose is used as one of the raw materials in the deep eutectic solvent of the present invention, which also provides a carbon source for subsequent fermentation.
本发明通过长双歧杆菌、婴儿双歧杆菌进行发酵,发酵的产物中含有丰富的维生素、氨基酸和滋养细胞的矿物质等,加快皮肤代谢、修复受损肌肤;同时,也能提高原料中活性组分的溶出,使得发酵产物中含有丰富的黄酮、有机酸、萜醇、多糖、皂苷等物质。两种菌种的发酵作用,也具有协同增效的作用。The present invention uses Bifidobacterium longum and Bifidobacterium infantis for fermentation, and the fermented product contains rich vitamins, amino acids and minerals that nourish cells, etc., which accelerates skin metabolism and repairs damaged skin; at the same time, it can also improve the dissolution of active components in the raw materials, so that the fermented product contains rich flavonoids, organic acids, terpenoids, polysaccharides, saponins and other substances. The fermentation of the two strains also has a synergistic effect.
发酵产物经过醇沉获得的多糖组合物具有非常出色的保湿作用、美白和抗氧化特性。经过大孔树脂分离纯化,获得的活性混合物中含有丰富的黄酮/皂苷复合物。The polysaccharide composition obtained by alcohol precipitation of the fermentation product has excellent moisturizing, whitening and antioxidant properties. After separation and purification by macroporous resin, the obtained active mixture contains rich flavonoids/saponin complexes.
其中,白桦树皮提取物中含有丰富的挥发油和三萜烯醇等成分,具有抗菌消炎作用;珠丝毛蓝耳草根提取物具有良好的去角质、去斑增白作用,可与抗菌消炎的白桦树皮提取物复配使用,对面部黄褐斑、雀斑、黑色素沉着等有很好的修复功效,另对粉刺亦有明显效果。欧洲李提取物含有传统的滋润护肤成分,其籽类提取物具有修复、舒缓的作用,能帮助肌肤修复暗黄无光的肤色,深度滋润肌肤。牡丹根提取物含有抗氧化成分,对金属蛋白酶和弹性蛋白酶有抑制作用,具有延缓肌肤老化的作用,含有胶原纤维凝胶,具有收缩作用,可以紧致皮肤,去除细纹、皱纹和眼袋。当归根提取物可促进血红蛋白及红细胞生成,其所含阿魏酸能改善外周循环,有抗氧化及清除自由基作用,提示有一定延缓衰老作用。Among them, birch bark extract contains rich volatile oils and triterpenoid alcohols, which have antibacterial and anti-inflammatory effects; the root extract of the blue ear grass has good exfoliating, spot removal and whitening effects, and can be used in combination with the antibacterial and anti-inflammatory birch bark extract. It has a good repair effect on facial chloasma, freckles, melanin deposition, etc., and also has a significant effect on acne. European plum extract contains traditional moisturizing skin care ingredients, and its seed extract has a repairing and soothing effect, which can help the skin repair the dull and dull skin color and deeply moisturize the skin. Peony root extract contains antioxidant ingredients, which have an inhibitory effect on metalloproteinases and elastases, and has the effect of delaying skin aging. It contains collagen fiber gel, which has a contraction effect, can tighten the skin, and remove fine lines, wrinkles and eye bags. Angelica root extract can promote hemoglobin and erythrocyte production. The ferulic acid it contains can improve peripheral circulation, has antioxidant and free radical scavenging effects, indicating that it has a certain anti-aging effect.
发酵的过程一方面产生了丰富的发酵副产物,同时促进了双歧杆菌的大量增殖,经过液氮冷冻-室温溶解处理,双歧杆菌菌壁破裂,内容物溶出,制得的二裂酵母溶胞物可以调节去乙酰化酶-6基因的表达,有助于延长细胞寿命,延缓衰老,具有美白、抗氧化、抗老化的功效。On the one hand, the fermentation process produces abundant fermentation by-products, and on the other hand, it promotes the massive proliferation of bifidobacteria. After liquid nitrogen freezing-room temperature thawing treatment, the bifidobacterium bacterial wall is broken and the contents are dissolved. The obtained bifid yeast lysate can regulate the expression of the deacetylase-6 gene, help to prolong cell life, delay aging, and has whitening, anti-oxidation and anti-aging effects.
本发明制得的水蛭素/根皮素/鞣花酸螯合复合物将水蛭素、根皮素、鞣花酸在单宁酸的聚合作用下,形成了复合的网络多分子结构的复合物,根皮素结构具有较好的抗氧化、抗炎、保湿作用,水蛭素部分加速细胞新陈代谢,疏通毛细血管,改善面部微循环,抑制和减少黑色素的生长,具有消炎、消肿、消退面部色素沉淀的作用;鞣花酸结构可以阻断酪氨酸酶的活性,对抗自由基,帮助肌肤发挥抗老化作用,阻止细纹、皱纹等皮肤问题产生,阻止皮肤黑色素堆积,加速黑色素分解,并从根源上阻止黑色素生成,帮助皮肤起到美白的作用,提亮肤色、淡化色斑。进一步通过与银离子形成络合物,银离子的参与可以抑制黑色素细胞的活性和功能,减少黑色素产生,达到美白效果。同时,还可以抑制酪氨酸酶的活性,从而减少黑色素的合成。The hirudin/phloretin/ellagic acid chelate complex prepared by the present invention forms a complex of a composite network multi-molecular structure by hirudin, phloretin, and ellagic acid under the polymerization of tannic acid, and the phloretin structure has good anti-oxidation, anti-inflammatory, and moisturizing effects, and the hirudin part accelerates cell metabolism, dredges capillaries, improves facial microcirculation, inhibits and reduces the growth of melanin, and has the effects of anti-inflammatory, detumescence, and disappearance of facial pigmentation; the ellagic acid structure can block the activity of tyrosinase, resist free radicals, help the skin to play an anti-aging effect, prevent the skin problems such as fine lines and wrinkles from occurring, prevent the accumulation of skin melanin, accelerate the decomposition of melanin, and prevent the generation of melanin from the root, help the skin to play a whitening effect, brighten the skin color, and dilute spots. Further by forming a complex with silver ions, the participation of silver ions can inhibit the activity and function of melanocytes, reduce melanin production, and achieve a whitening effect. At the same time, the activity of tyrosinase can also be inhibited, thereby reducing the synthesis of melanin.
本发明制得的淡斑美白精华液具有较好的美白、淡斑、紧致皮肤、抗氧化、抗炎、保湿、提高皮肤弹性、延缓衰老的效果,且原料来源广,制备方法简单,具有广阔的应用前景。The spot-lightening and whitening essence prepared by the invention has good whitening, spot-lightening, skin-tightening, anti-oxidation, anti-inflammatory, moisturizing, skin elasticity-enhancing and anti-aging effects, and has a wide source of raw materials, a simple preparation method and broad application prospects.
具体实施方式Detailed ways
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
纤维素酶,1.1万U/g,果胶酶,6万U/g,购于夏盛(北京)生物科技开发有限公司。Cellulase, 11,000 U/g, and pectinase, 60,000 U/g, were purchased from Xiasheng (Beijing) Biotechnology Development Co., Ltd.
长双歧杆菌,100亿cfu/g,购于广东鸿佑生物科技有限公司,婴儿双歧杆菌,100亿cfu/g,购于湖北鸣拓生物科技有限公司。Bifidobacterium longum, 10 billion cfu/g, was purchased from Guangdong Hongyou Biotechnology Co., Ltd., and Bifidobacterium infantis, 10 billion cfu/g, was purchased from Hubei Mingtuo Biotechnology Co., Ltd.
菌种种子液的制备方法:将菌种接种至高氏培养基中,37℃,100r/min,活化培养24h,制得含菌量为108-109cfu/mL的菌种种子液。Preparation method of bacterial seed solution: inoculate the bacterial strain into Gould's medium, activate and culture at 37°C, 100 r/min for 24 hours, and obtain bacterial seed solution with a bacterial content of 10 8 -10 9 cfu/mL.
制备例1植物提取物的制备方法包括以下步骤:Preparation Example 1 The preparation method of the plant extract comprises the following steps:
S1.深共熔溶剂中酶解:将3重量份白桦树皮、1重量份珠丝毛蓝耳草根、7重量份欧洲李、3重量份牡丹根、1重量份当归根分别洗净,干燥,粉碎,制得混合粉,将10重量份混合粉加入50重量份含有深共熔溶剂的水溶液中,加入复合酶,所述复合酶的添加量为体系总质量的2wt%,40℃酶解1h,灭酶,制得酶解产物;S1. Enzymatic hydrolysis in a deep eutectic solvent: 3 parts by weight of birch bark, 1 part by weight of blue ear grass root, 7 parts by weight of European plum, 3 parts by weight of peony root, and 1 part by weight of angelica root were washed, dried, and crushed to obtain a mixed powder, 10 parts by weight of the mixed powder were added to 50 parts by weight of an aqueous solution containing a deep eutectic solvent, and a composite enzyme was added, wherein the amount of the composite enzyme added was 2 wt % of the total mass of the system, and the enzymatic hydrolysis was performed at 40° C. for 1 h, and the enzyme was inactivated to obtain an enzymatic hydrolysis product;
所述复合酶由纤维素酶和果胶酶混合组成,质量比为10:3;The complex enzyme is composed of a mixture of cellulase and pectinase, with a mass ratio of 10:3;
所述含有深共熔溶剂的水溶液中水的含量为40wt%,所述深共熔溶剂由氯化胆碱和葡萄糖按照摩尔比1:1混合制备而成;The water content in the aqueous solution containing the deep eutectic solvent is 40 wt %, and the deep eutectic solvent is prepared by mixing choline chloride and glucose in a molar ratio of 1:1;
S2.发酵:将步骤S1中的酶解产物灭菌,接种长双歧杆菌、婴儿双歧杆菌菌种种子液,所述长双歧杆菌、婴儿双歧杆菌菌种种子液的接种量分别为1v/v%和2v/v%,无氧条件下,36℃,150r/min,发酵培养24h,过滤,固体洗涤,收集洗脱液浓缩得到菌液,滤液留用;S2. Fermentation: The enzymatic hydrolysate in step S1 was sterilized and inoculated with Bifidobacterium longum and Bifidobacterium infantis seed solution, wherein the inoculation amount of Bifidobacterium longum and Bifidobacterium infantis seed solution was 1v/v% and 2v/v%, respectively, under anaerobic conditions, at 36°C, 150r/min, and the fermentation culture was carried out for 24h, filtered, the solid was washed, the eluate was collected and concentrated to obtain a bacterial solution, and the filtrate was retained;
S3.二裂酵母溶胞物的制备:将步骤S2制得的菌液液氮冷冻,室温溶解,离心,收集上清液,冷冻干燥,制得二裂酵母溶胞物;S3. Preparation of bifid yeast lysate: The bacterial solution obtained in step S2 was frozen in liquid nitrogen, dissolved at room temperature, centrifuged, the supernatant was collected, and freeze-dried to obtain bifid yeast lysate;
S4.多糖组合物的制备:向步骤S2制得的滤液中加入乙醇至体系中乙醇含量为60wt%,沉淀3h,离心,收集固体,上清液回收乙醇,得到的溶液留用,固体洗涤,干燥,制得多糖组合物;S4. Preparation of a polysaccharide composition: adding ethanol to the filtrate obtained in step S2 until the ethanol content in the system is 60 wt %, precipitating for 3 h, centrifuging, collecting the solid, recovering ethanol from the supernatant, retaining the obtained solution, washing the solid, and drying to obtain a polysaccharide composition;
S5.分离纯化:将10重量份有机溶剂加入20重量份步骤S3中的溶液中,萃取,收集有机相,将有机相减压除去溶剂,用70wt%的乙醇稀释至1mg/mL上样,湿法装柱获得AB-8大孔树脂层析柱,层析柱规格为15mm*500mm,柱体积为50mL,收集70wt%乙醇浓度的洗脱液,减压除去乙醇,干燥,获得黄酮/皂苷复合物;S5. Separation and purification: adding 10 parts by weight of an organic solvent to 20 parts by weight of the solution in step S3, extracting, collecting the organic phase, removing the solvent from the organic phase under reduced pressure, diluting it with 70 wt % ethanol to 1 mg / mL for loading, wet packing to obtain an AB-8 macroporous resin chromatography column, the chromatography column specification is 15 mm * 500 mm, the column volume is 50 mL, collecting the eluate with a concentration of 70 wt % ethanol, removing the ethanol under reduced pressure, and drying to obtain a flavonoid / saponin complex;
所述有机溶剂为二氯甲烷和四氢呋喃的混合溶剂,体积比为3:1;The organic solvent is a mixed solvent of dichloromethane and tetrahydrofuran, with a volume ratio of 3:1;
S6.保鲜剂的制备:将10重量份维生素C和3重量份维生素E搅拌混合10min,制得保鲜剂;S6. Preparation of preservative: 10 parts by weight of vitamin C and 3 parts by weight of vitamin E were stirred and mixed for 10 min to obtain a preservative;
S7.植物提取物的制备:将10重量份步骤S3制得的二裂酵母溶胞物、15重量份步骤S4制得的多糖组合物、17重量份步骤S5制得的黄酮/皂苷复合物、2重量份步骤S6制得的保鲜剂搅拌混合20min,制得植物提取物。S7. Preparation of plant extract: 10 parts by weight of the bifida yeast lysate obtained in step S3, 15 parts by weight of the polysaccharide composition obtained in step S4, 17 parts by weight of the flavonoid/saponin complex obtained in step S5, and 2 parts by weight of the preservative obtained in step S6 were stirred and mixed for 20 minutes to obtain a plant extract.
制备例2植物提取物的制备方法包括以下步骤:Preparation Example 2 The preparation method of the plant extract comprises the following steps:
S1.深共熔溶剂中酶解:将5重量份白桦树皮、3重量份珠丝毛蓝耳草根、12重量份欧洲李、5重量份牡丹根、2重量份当归根分别洗净,干燥,粉碎,制得混合粉,将10重量份混合粉加入70重量份含有深共熔溶剂的水溶液中,加入复合酶,所述复合酶的添加量为体系总质量的3wt%,50℃酶解3h,灭酶,制得酶解产物;S1. Enzymatic hydrolysis in a deep eutectic solvent: 5 parts by weight of birch bark, 3 parts by weight of blue ear grass root, 12 parts by weight of European plum, 5 parts by weight of peony root, and 2 parts by weight of angelica root were washed, dried, and crushed to obtain a mixed powder, 10 parts by weight of the mixed powder were added to 70 parts by weight of an aqueous solution containing a deep eutectic solvent, and a composite enzyme was added, wherein the amount of the composite enzyme added was 3wt% of the total mass of the system, and the enzymatic hydrolysis was performed at 50°C for 3h, and the enzyme was inactivated to obtain an enzymatic hydrolysis product;
所述复合酶由纤维素酶和果胶酶混合组成,质量比为15:5;The complex enzyme is composed of a mixture of cellulase and pectinase, with a mass ratio of 15:5;
所述含有深共熔溶剂的水溶液中水的含量为60wt%,所述深共熔溶剂由氯化胆碱和葡萄糖按照摩尔比1:1混合制备而成;The water content in the aqueous solution containing the deep eutectic solvent is 60 wt %, and the deep eutectic solvent is prepared by mixing choline chloride and glucose in a molar ratio of 1:1;
S2.发酵:将步骤S1中的酶解产物灭菌,接种长双歧杆菌、婴儿双歧杆菌菌种种子液,所述长双歧杆菌、婴儿双歧杆菌菌种种子液的接种量分别为2v/v%和4v/v%,无氧条件下,39℃,200r/min,发酵培养48h,过滤,固体洗涤,收集洗脱液浓缩得到菌液,滤液留用;S2. Fermentation: The enzymatic hydrolysate in step S1 was sterilized and inoculated with Bifidobacterium longum and Bifidobacterium infantis seed solution, wherein the inoculation amount of Bifidobacterium longum and Bifidobacterium infantis seed solution was 2 v / v% and 4 v / v%, respectively, under anaerobic conditions, 39 ° C, 200 r / min, and the fermentation culture was carried out for 48 h, filtered, the solid was washed, and the eluate was collected and concentrated to obtain a bacterial solution, and the filtrate was retained;
S3.二裂酵母溶胞物的制备:将步骤S2制得的菌液液氮冷冻,室温溶解,离心,收集上清液,冷冻干燥,制得二裂酵母溶胞物;S3. Preparation of bifid yeast lysate: The bacterial solution obtained in step S2 was frozen in liquid nitrogen, dissolved at room temperature, centrifuged, the supernatant was collected, and freeze-dried to obtain bifid yeast lysate;
S4.多糖组合物的制备:向步骤S2制得的滤液中加入乙醇至体系中乙醇含量为80wt%,沉淀5h,离心,收集固体,上清液回收乙醇,得到的溶液留用,固体洗涤,干燥,制得多糖组合物;S4. Preparation of a polysaccharide composition: adding ethanol to the filtrate obtained in step S2 until the ethanol content in the system is 80 wt %, precipitating for 5 h, centrifuging, collecting the solid, recovering ethanol from the supernatant, retaining the resulting solution, washing the solid, and drying to obtain a polysaccharide composition;
S5.分离纯化:将30重量份有机溶剂加入40重量份步骤S3中的溶液中,萃取,收集有机相,将有机相减压除去溶剂,用80wt%的乙醇稀释至1.5mg/mL上样,湿法装柱获得AB-8大孔树脂层析柱,层析柱规格为15mm*500mm,柱体积为50mL,收集80wt%乙醇浓度的洗脱液,减压除去乙醇,干燥,获得黄酮/皂苷复合物;S5. Separation and purification: adding 30 parts by weight of an organic solvent to 40 parts by weight of the solution in step S3, extracting, collecting the organic phase, removing the solvent from the organic phase under reduced pressure, diluting it with 80 wt % ethanol to 1.5 mg / mL for loading, wet packing to obtain an AB-8 macroporous resin chromatography column, the chromatography column specification is 15 mm * 500 mm, the column volume is 50 mL, collecting the eluate with an ethanol concentration of 80 wt %, removing the ethanol under reduced pressure, and drying to obtain a flavonoid / saponin complex;
所述有机溶剂为二氯甲烷和四氢呋喃的混合溶剂,体积比为5:1;The organic solvent is a mixed solvent of dichloromethane and tetrahydrofuran, with a volume ratio of 5:1;
S6.保鲜剂的制备:将15重量份维生素C和7重量份维生素E搅拌混合10min,制得保鲜剂;S6. Preparation of preservative: 15 parts by weight of vitamin C and 7 parts by weight of vitamin E were stirred and mixed for 10 min to obtain a preservative;
S7.植物提取物的制备:将12重量份步骤S3制得的二裂酵母溶胞物、22重量份步骤S4制得的多糖组合物、20重量份步骤S5制得的黄酮/皂苷复合物、4重量份步骤S6制得的保鲜剂搅拌混合20min,制得植物提取物。S7. Preparation of plant extract: 12 parts by weight of the bifida yeast lysate obtained in step S3, 22 parts by weight of the polysaccharide composition obtained in step S4, 20 parts by weight of the flavonoid/saponin complex obtained in step S5, and 4 parts by weight of the preservative obtained in step S6 were stirred and mixed for 20 minutes to obtain a plant extract.
制备例3植物提取物的制备方法包括以下步骤:Preparation Example 3 The preparation method of the plant extract comprises the following steps:
S1.深共熔溶剂中酶解:将4重量份白桦树皮、2重量份珠丝毛蓝耳草根、10重量份欧洲李、4重量份牡丹根、1.5重量份当归根分别洗净,干燥,粉碎,制得混合粉,将10重量份混合粉加入60重量份含有深共熔溶剂的水溶液中,加入复合酶,所述复合酶的添加量为体系总质量的2.5wt%,46℃酶解2h,灭酶,制得酶解产物;S1. Enzymatic hydrolysis in a deep eutectic solvent: 4 parts by weight of birch bark, 2 parts by weight of blue ear grass root, 10 parts by weight of European plum, 4 parts by weight of peony root, and 1.5 parts by weight of angelica root were washed, dried, and crushed to obtain a mixed powder, 10 parts by weight of the mixed powder were added to 60 parts by weight of an aqueous solution containing a deep eutectic solvent, and a composite enzyme was added, wherein the amount of the composite enzyme added was 2.5 wt% of the total mass of the system, and the enzymatic hydrolysis was performed at 46° C. for 2 h, and the enzyme was inactivated to obtain an enzymatic hydrolysis product;
所述复合酶由纤维素酶和果胶酶混合组成,质量比为12:4;The complex enzyme is composed of a mixture of cellulase and pectinase, with a mass ratio of 12:4;
所述含有深共熔溶剂的水溶液中水的含量为50wt%,所述深共熔溶剂由氯化胆碱和葡萄糖按照摩尔比1:1混合制备而成;The water content in the aqueous solution containing the deep eutectic solvent is 50 wt %, and the deep eutectic solvent is prepared by mixing choline chloride and glucose in a molar ratio of 1:1;
S2.发酵:将步骤S1中的酶解产物灭菌,接种长双歧杆菌、婴儿双歧杆菌菌种种子液,所述长双歧杆菌、婴儿双歧杆菌菌种种子液的接种量分别为1.2v/v%和3v/v%,无氧条件下,37℃,170r/min,发酵培养36h,过滤,固体洗涤,收集洗脱液浓缩得到菌液,滤液留用;S2. Fermentation: The enzymatic hydrolysate in step S1 was sterilized and inoculated with Bifidobacterium longum and Bifidobacterium infantis seed solution, wherein the inoculation amount of Bifidobacterium longum and Bifidobacterium infantis seed solution was 1.2 v / v% and 3 v / v%, respectively, under anaerobic conditions, 37 ° C, 170 r / min, and the fermentation culture was carried out for 36 h, filtered, the solid was washed, and the eluate was collected and concentrated to obtain a bacterial solution, and the filtrate was retained;
S3.二裂酵母溶胞物的制备:将步骤S2制得的菌液液氮冷冻,室温溶解,离心,收集上清液,冷冻干燥,制得二裂酵母溶胞物;S3. Preparation of bifid yeast lysate: The bacterial solution obtained in step S2 was frozen in liquid nitrogen, dissolved at room temperature, centrifuged, the supernatant was collected, and freeze-dried to obtain bifid yeast lysate;
S4.多糖组合物的制备:向步骤S2制得的滤液中加入乙醇至体系中乙醇含量为70wt%,沉淀4h,离心,收集固体,上清液回收乙醇,得到的溶液留用,固体洗涤,干燥,制得多糖组合物;S4. Preparation of a polysaccharide composition: adding ethanol to the filtrate obtained in step S2 until the ethanol content in the system is 70 wt %, precipitating for 4 h, centrifuging, collecting the solid, recovering ethanol from the supernatant, retaining the obtained solution, washing the solid, and drying to obtain a polysaccharide composition;
S5.分离纯化:将20重量份有机溶剂加入30重量份步骤S3中的溶液中,萃取,收集有机相,将有机相减压除去溶剂,用75wt%的乙醇稀释至1.5mg/mL上样,湿法装柱获得AB-8大孔树脂层析柱,层析柱规格为15mm*500mm,柱体积为50mL,收集75wt%乙醇浓度的洗脱液,减压除去乙醇,干燥,获得黄酮/皂苷复合物;S5. Separation and purification: adding 20 parts by weight of an organic solvent to 30 parts by weight of the solution in step S3, extracting, collecting the organic phase, removing the solvent from the organic phase under reduced pressure, diluting with 75 wt% ethanol to 1.5 mg/mL for loading, wet packing to obtain an AB-8 macroporous resin chromatography column, the chromatography column having a specification of 15 mm*500 mm, a column volume of 50 mL, collecting an eluate having an ethanol concentration of 75 wt%, removing ethanol under reduced pressure, and drying to obtain a flavonoid/saponin complex;
所述有机溶剂为二氯甲烷和四氢呋喃的混合溶剂,体积比为4:1;The organic solvent is a mixed solvent of dichloromethane and tetrahydrofuran, with a volume ratio of 4:1;
S6.保鲜剂的制备:将12重量份维生素C和5重量份维生素E搅拌混合10min,制得保鲜剂;S6. Preparation of preservative: 12 parts by weight of vitamin C and 5 parts by weight of vitamin E were stirred and mixed for 10 min to obtain a preservative;
S7.植物提取物的制备:将11重量份步骤S3制得的二裂酵母溶胞物、20重量份步骤S4制得的多糖组合物、18重量份步骤S5制得的黄酮/皂苷复合物、3重量份步骤S6制得的保鲜剂搅拌混合20min,制得植物提取物。S7. Preparation of plant extract: 11 parts by weight of the bifida yeast lysate obtained in step S3, 20 parts by weight of the polysaccharide composition obtained in step S4, 18 parts by weight of the flavonoid/saponin complex obtained in step S5, and 3 parts by weight of the preservative obtained in step S6 were stirred and mixed for 20 minutes to obtain a plant extract.
制备例4Preparation Example 4
与制备例3相比,不同之处在于,复合酶为单一的纤维素酶。Compared with Preparation Example 3, the difference is that the composite enzyme is a single cellulase.
制备例5Preparation Example 5
与制备例3相比,不同之处在于,复合酶为单一的果胶酶。Compared with Preparation Example 3, the difference is that the complex enzyme is a single pectinase.
对比制备例1Comparative Preparation Example 1
与制备例3相比,不同之处在于,步骤S1中未添加复合酶。Compared with Preparation Example 3, the difference is that no complex enzyme is added in step S1.
对比制备例2Comparative Preparation Example 2
与制备例3相比,不同之处在于,步骤S2中未接种长双歧杆菌菌种种子液。Compared with Preparation Example 3, the difference is that the seed liquid of Bifidobacterium longum is not inoculated in step S2.
对比制备例3Comparative Preparation Example 3
与制备例3相比,不同之处在于,步骤S2中未接种婴儿双歧杆菌菌种种子液。Compared with Preparation Example 3, the difference is that the seed liquid of Bifidobacterium infantis is not inoculated in step S2.
对比制备例4Comparative Preparation Example 4
与制备例3相比,不同之处在于,未进行步骤S2。Compared with Preparation Example 3, the difference is that step S2 is not performed.
对比制备例5Comparative Preparation Example 5
与制备例3相比,不同之处在于,步骤S7中未添加二裂酵母溶胞物。Compared with Preparation Example 3, the difference is that no bifida yeast lysate is added in step S7.
对比制备例6Comparative Preparation Example 6
与制备例3相比,不同之处在于,步骤S7中未添加多糖组合物。Compared with Preparation Example 3, the difference is that no polysaccharide composition is added in step S7.
对比制备例7Comparative Preparation Example 7
与制备例3相比,不同之处在于,步骤S7中未添加黄酮/皂苷复合物。Compared with Preparation Example 3, the difference is that no flavonoid/saponin complex is added in step S7.
制备例6水蛭素/根皮素/鞣花酸螯合复合物的制备Preparation Example 6 Preparation of hirudin/phloretin/ellagic acid chelate complex
方法如下:Methods as below:
T1.将12重量份水蛭素、3重量份根皮素、2重量份鞣花酸加入200重量份水中,加入2重量份三羟甲基氨基甲烷和5重量份单宁酸,调节溶液pH值为8.2,加热至40℃,搅拌反应1h,制得复合物;T1. 12 parts by weight of hirudin, 3 parts by weight of phloretin, and 2 parts by weight of ellagic acid were added to 200 parts by weight of water, 2 parts by weight of tris(hydroxymethyl)aminomethane and 5 parts by weight of tannic acid were added, the pH value of the solution was adjusted to 8.2, heated to 40 ° C, and stirred for 1 h to obtain a complex;
T2.将10重量份步骤T1制得的复合物加入100重量份水中,加入0.2重量份硝酸银,搅拌反应20min,透析,干燥,制得水蛭素/根皮素/鞣花酸螯合复合物。T2. Add 10 parts by weight of the complex prepared in step T1 to 100 parts by weight of water, add 0.2 parts by weight of silver nitrate, stir and react for 20 minutes, dialyze, and dry to obtain a hirudin/phloretin/ellagic acid chelate complex.
制备例7水蛭素/根皮素/鞣花酸螯合复合物的制备Preparation Example 7 Preparation of hirudin/phloretin/ellagic acid chelate complex
方法如下:Methods as below:
T1.将15重量份水蛭素、5重量份根皮素、4重量份鞣花酸加入200重量份水中,加入4重量份三羟甲基氨基甲烷和7重量份单宁酸,调节溶液pH值为8.7,加热至50℃,搅拌反应3h,制得复合物;T1. 15 parts by weight of hirudin, 5 parts by weight of phloretin, and 4 parts by weight of ellagic acid were added to 200 parts by weight of water, 4 parts by weight of tris(hydroxymethyl)aminomethane and 7 parts by weight of tannic acid were added, the pH value of the solution was adjusted to 8.7, heated to 50 ° C, and stirred for 3 hours to obtain a complex;
T2.将15重量份步骤T1制得的复合物加入100重量份水中,加入0.5重量份硝酸银,搅拌反应30min,透析,干燥,制得水蛭素/根皮素/鞣花酸螯合复合物。T2. Add 15 parts by weight of the complex prepared in step T1 to 100 parts by weight of water, add 0.5 parts by weight of silver nitrate, stir and react for 30 minutes, dialyze, and dry to obtain a hirudin/phloretin/ellagic acid chelate complex.
制备例8水蛭素/根皮素/鞣花酸螯合复合物的制备Preparation Example 8 Preparation of hirudin/phloretin/ellagic acid chelate complex
方法如下:Methods as below:
T1.将13重量份水蛭素、4重量份根皮素、3重量份鞣花酸加入200重量份水中,加入3重量份三羟甲基氨基甲烷和6重量份单宁酸,调节溶液pH值为8.5,加热至45℃,搅拌反应2h,制得复合物;T1. 13 parts by weight of hirudin, 4 parts by weight of phloretin, and 3 parts by weight of ellagic acid were added to 200 parts by weight of water, 3 parts by weight of tris(hydroxymethyl)aminomethane and 6 parts by weight of tannic acid were added, the pH value of the solution was adjusted to 8.5, heated to 45 ° C, and stirred for 2 hours to obtain a complex;
T2.将12重量份步骤T1制得的复合物加入100重量份水中,加入0.3重量份硝酸银,搅拌反应25min,透析,干燥,制得水蛭素/根皮素/鞣花酸螯合复合物。T2. Add 12 parts by weight of the complex prepared in step T1 to 100 parts by weight of water, add 0.3 parts by weight of silver nitrate, stir and react for 25 minutes, dialyze, and dry to obtain a hirudin/phloretin/ellagic acid chelate complex.
对比制备例8Comparative Preparation Example 8
与制备例8相比,不同之处在于,步骤T1中未添加根皮素。Compared with Preparation Example 8, the difference is that phloretin is not added in step T1.
对比制备例9Comparative Preparation Example 9
与制备例8相比,不同之处在于,步骤T1中未添加鞣花酸。Compared with Preparation Example 8, the difference is that ellagic acid is not added in step T1.
对比制备例10Comparative Preparation Example 10
与制备例8相比,不同之处在于,步骤T1中未添加水蛭素。Compared with Preparation Example 8, the difference is that hirudin is not added in step T1.
对比制备例11Comparative Preparation Example 11
与制备例8相比,不同之处在于,步骤T1中未添加单宁酸。Compared with Preparation Example 8, the difference is that tannic acid is not added in step T1.
对比制备例12Comparative Preparation Example 12
与制备例8相比,不同之处在于,未进行步骤T2。Compared with Preparation Example 8, the difference is that step T2 is not performed.
实施例1Example 1
本实施例提供一种淡斑美白精华液,制备方法包括以下步骤:This embodiment provides a whitening and lightening essence, the preparation method of which comprises the following steps:
(1)将5重量份甘油、0.3重量份黄原胶加入40重量份去离子水中,加热至70℃,300r/min搅拌10min,制得A相;(1) 5 parts by weight of glycerol and 0.3 parts by weight of xanthan gum were added to 40 parts by weight of deionized water, heated to 70° C., and stirred at 300 r/min for 10 min to prepare phase A;
(2)将10重量份甘油三(乙基己酸)酯、0.5重量份山梨坦橄榄油酸酯、3重量份制备例6制得的水蛭素/根皮素/鞣花酸螯合复合物混合,加热至70℃,300r/min搅拌10min,制得B相;(2) 10 parts by weight of glyceryl tri(ethylhexanoate), 0.5 parts by weight of sorbitan olivate, and 3 parts by weight of the hirudin/phloretin/ellagic acid chelate complex prepared in Preparation Example 6 were mixed, heated to 70° C., and stirred at 300 r/min for 10 min to prepare phase B;
(3)将B相加入A相中,300r/min搅拌5min,7000r/min乳化10-20min,保温10-20min,降温;(3) Add phase B to phase A, stir at 300 r/min for 5 min, emulsify at 7000 r/min for 10-20 min, keep warm for 10-20 min, and cool down;
(4)降温至35℃后,加入10重量份制备例1制得的植物提取物,300r/min搅拌5min,过滤,制得淡斑美白精华液。(4) After cooling to 35° C., 10 parts by weight of the plant extract prepared in Preparation Example 1 was added, stirred at 300 r/min for 5 min, and filtered to prepare a spot-lightening and whitening essence.
实施例2Example 2
本实施例提供一种淡斑美白精华液,制备方法包括以下步骤:This embodiment provides a whitening and lightening essence, the preparation method of which comprises the following steps:
(1)将10重量份己二醇、1重量份聚丙烯酸酯交联聚合物-6加入60重量份去离子水中,加热至80℃,500r/min搅拌20min,制得A相;(1) adding 10 parts by weight of hexanediol and 1 part by weight of polyacrylate cross-linked polymer-6 to 60 parts by weight of deionized water, heating to 80° C., and stirring at 500 r/min for 20 min to prepare phase A;
(2)将20重量份聚二甲基硅氧烷、3重量份鲸蜡硬脂醇橄榄油酸酯、5重量份制备例7制得的水蛭素/根皮素/鞣花酸螯合复合物混合,加热至80℃,500r/min搅拌20min,制得B相;(2) 20 parts by weight of polydimethylsiloxane, 3 parts by weight of cetearyl olivate, and 5 parts by weight of the hirudin/phloretin/ellagic acid chelate complex prepared in Preparation Example 7 were mixed, heated to 80° C., and stirred at 500 r/min for 20 min to prepare phase B;
(3)将B相加入A相中,500r/min搅拌15min,10000r/min乳化20min,保温20min,降温;(3) Add phase B to phase A, stir at 500 r/min for 15 min, emulsify at 10,000 r/min for 20 min, keep warm for 20 min, and cool down;
(4)降温至40℃后,加入20重量份制备例2制得的植物提取物,500r/min搅拌15min,过滤,制得淡斑美白精华液。(4) After cooling to 40° C., 20 parts by weight of the plant extract prepared in Preparation Example 2 was added, stirred at 500 r/min for 15 min, and filtered to prepare a spot-lightening and whitening essence.
实施例3Example 3
本实施例提供一种淡斑美白精华液,制备方法包括以下步骤:This embodiment provides a whitening and lightening essence, the preparation method of which comprises the following steps:
(1)将7重量份透明质酸钠、0.7重量份卡波姆加入50重量份去离子水中,加热至75℃,400r/min搅拌15min,制得A相;(1) 7 parts by weight of sodium hyaluronate and 0.7 parts by weight of carbomer were added to 50 parts by weight of deionized water, heated to 75° C., and stirred at 400 r/min for 15 min to prepare phase A;
(2)将15重量份癸酸甘油三酯、1.5重量份甘油硬脂酸酯、4重量份制备例8制得的水蛭素/根皮素/鞣花酸螯合复合物混合,加热至75℃,400r/min搅拌15min,制得B相;(2) 15 parts by weight of capric triglyceride, 1.5 parts by weight of glyceryl stearate, and 4 parts by weight of the hirudin/phloretin/ellagic acid chelate complex prepared in Preparation Example 8 were mixed, heated to 75° C., and stirred at 400 r/min for 15 min to prepare phase B;
(3)将B相加入A相中,400r/min搅拌10min,8000r/min乳化15min,保温15min,降温;(3) Add phase B to phase A, stir at 400 r/min for 10 min, emulsify at 8000 r/min for 15 min, keep warm for 15 min, and cool down;
(4)降温至37℃后,加入15重量份制备例3制得的植物提取物,400r/min搅拌10min,过滤,制得淡斑美白精华液。(4) After cooling to 37° C., 15 parts by weight of the plant extract prepared in Preparation Example 3 was added, stirred at 400 r/min for 10 min, and filtered to prepare a spot-lightening and whitening essence.
实施例4Example 4
与实施例3相比,不同之处在于,植物提取物由制备例4制得。Compared with Example 3, the difference is that the plant extract is prepared by Preparation Example 4.
实施例5Example 5
与实施例3相比,不同之处在于,植物提取物由制备例5制得。Compared with Example 3, the difference is that the plant extract is prepared by Preparation Example 5.
对比例1Comparative Example 1
与实施例3相比,不同之处在于,植物提取物由对比制备例1制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 1.
对比例2Comparative Example 2
与实施例3相比,不同之处在于,植物提取物由对比制备例2制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 2.
对比例3Comparative Example 3
与实施例3相比,不同之处在于,植物提取物由对比制备例3制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 3.
对比例4Comparative Example 4
与实施例3相比,不同之处在于,植物提取物由对比制备例4制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 4.
对比例5Comparative Example 5
与实施例3相比,不同之处在于,植物提取物由对比制备例5制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 5.
对比例6Comparative Example 6
与实施例3相比,不同之处在于,植物提取物由对比制备例6制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 6.
对比例7Comparative Example 7
与实施例3相比,不同之处在于,植物提取物由对比制备例7制得。Compared with Example 3, the difference is that the plant extract is prepared by Comparative Preparation Example 7.
对比例8Comparative Example 8
与实施例3相比,不同之处在于,水蛭素/根皮素/鞣花酸螯合复合物由对比制备例8制得。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is prepared by Comparative Preparation Example 8.
对比例9Comparative Example 9
与实施例3相比,不同之处在于,水蛭素/根皮素/鞣花酸螯合复合物由对比制备例9制得。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is prepared by Comparative Preparation Example 9.
对比例10Comparative Example 10
与实施例3相比,不同之处在于,水蛭素/根皮素/鞣花酸螯合复合物由对比制备例10制得。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is prepared by Comparative Preparation Example 10.
对比例11Comparative Example 11
与实施例3相比,不同之处在于,水蛭素/根皮素/鞣花酸螯合复合物由对比制备例11制得。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is prepared by Comparative Preparation Example 11.
对比例12Comparative Example 12
与实施例3相比,不同之处在于,水蛭素/根皮素/鞣花酸螯合复合物由对比制备例12制得。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is prepared by Comparative Preparation Example 12.
对比例13Comparative Example 13
与实施例3相比,不同之处在于,未添加植物提取物。Compared with Example 3, the difference is that no plant extract is added.
对比例14Comparative Example 14
与实施例3相比,不同之处在于,未添加水蛭素/根皮素/鞣花酸螯合复合物。Compared with Example 3, the difference is that the hirudin/phloretin/ellagic acid chelate complex is not added.
测试例1细胞毒性研究Test Example 1 Cytotoxicity Study
CCK-8法测定臻耀白的细胞毒性。收集对数生长期HaCaT细胞分别接种于96孔板,密度为2×105个/mL,每孔100μL,5%CO2,37℃条件下培养24h,每孔分别加入100μL含有实施例1-5或对比例1-14制得的淡斑美白精华液的DMEM完全培养基(淡斑美白精华液的浓度为200μg/mL),对照组仅加100μL DMEM完全培养基,每组3个复孔。继续培养24h后,CCK-8法测细胞存活率。结果见表1。The cytotoxicity of Zhenyaobai was determined by CCK-8 method. HaCaT cells in logarithmic growth phase were collected and inoculated into 96-well plates at a density of 2×10 5 cells/mL, 100 μL per well, 5% CO 2 , and cultured at 37°C for 24 hours. 100 μL of DMEM complete medium containing the whitening essence prepared in Example 1-5 or Comparative Example 1-14 was added to each well (the concentration of the whitening essence was 200 μg/mL), and only 100 μL of DMEM complete medium was added to the control group, with 3 replicates in each group. After continuing to culture for 24 hours, the cell survival rate was measured by CCK-8 method. The results are shown in Table 1.
表1Table 1
由上表可知,本发明制得的淡斑美白精华液对HaCaT细胞无毒性。It can be seen from the above table that the spot-lightening and whitening essence prepared by the present invention has no toxicity to HaCaT cells.
测试例2细胞酪氨酸酶活性和黑素含量研究Test Example 2 Study on Cellular Tyrosinase Activity and Melanin Content
取B16F10细胞以7×104个/mL分别接种于24和6孔板中,24孔板加入500μL,6孔板加入2mL。培养24h,按照实验分组(正常对照组、模型组、实施例1-5组、对比例1-14组)加入100nmoL/L促黑激素(α-MSH)进行诱导(除正常对照组),构建α-MSH诱导的黑色素高表达模型,再加入实施例1-5或对比例1-14制得的淡斑美白精华液(淡斑美白精华液的浓度为200μg/mL),每组设3个复孔,培养48h。结果见表2。B16F10 cells were inoculated at 7×10 4 cells/mL in 24-well and 6-well plates, 500 μL was added to the 24-well plate, and 2 mL was added to the 6-well plate. After 24 hours of culture, 100 nmol/L melanocyte stimulating hormone (α-MSH) was added according to the experimental groups (normal control group, model group, Example 1-5 group, Comparative Example 1-14 group) for induction (except the normal control group), and an α-MSH-induced melanin high expression model was constructed, and then the spot-lightening and whitening essence prepared in Example 1-5 or Comparative Example 1-14 was added (the concentration of the spot-lightening and whitening essence was 200 μg/mL), and 3 replicates were set for each group, and cultured for 48 hours. The results are shown in Table 2.
24孔细胞弃去上清液,用PBS清洗3次,裂解细胞,取上清液60μL于96孔板中,加入140μL的0.1%L-多巴胺,37℃孵育1h,于490nm波长处测各孔的吸光度(A),测定酪氨酸酶活性。The supernatant of 24-well cells was discarded, the plates were washed three times with PBS, the cells were lysed, 60 μL of the supernatant was placed in a 96-well plate, 140 μL of 0.1% L-dopamine was added, and the plates were incubated at 37°C for 1 h. The absorbance of each well was measured at a wavelength of 490 nm (A) to determine the tyrosinase activity.
6孔板细胞用PBS清洗3次后,每孔加入300μL的1.0mmoL/L NaOH溶液(含10%DMSO),在80℃充分裂解细胞1h,于405nm波长处测各孔吸光度(A),测定细胞黑素含量。After washing the cells in the 6-well plate three times with PBS, add 300 μL of 1.0 mmoL/L NaOH solution (containing 10% DMSO) to each well, fully lyse the cells at 80°C for 1 h, measure the absorbance (A) of each well at a wavelength of 405 nm, and determine the cellular melanin content.
表2Table 2
由上表可知,本发明实施例1-3制得的淡斑美白精华液具有较好的抑制酪氨酸酶活性,以及抑制细胞黑色素生成。It can be seen from the above table that the spot-lightening and whitening essences prepared in Examples 1-3 of the present invention have good effects of inhibiting tyrosinase activity and inhibiting cellular melanin production.
测试例3对·OH的清除率Test Example 3: Removal rate of OH
将实施例1-5或对比例1-14制得的淡斑美白精华液用去离子水稀释成1mg/mL,作为样品溶液。The spot-lightening and whitening essence prepared in Example 1-5 or Comparative Example 1-14 was diluted with deionized water to 1 mg/mL as a sample solution.
取2mL 1.00×10-2mol/L的水杨酸-乙醇溶液、2mL 9.00×10-3mol/L的FeSO4溶液和样品溶液加入试管中,然后加入2mL 8.8×10-2mol/L的H2O2溶液,摇匀后放置于37℃水浴中反应30min,在510nm处测定吸光度Ai;以2mL纯水代替水杨酸溶液测定吸光度Aj;用2mL纯水代替样品溶液来测定吸光度A0。根据公式计算·OH的清除率(%)。以维生素C作为对照组。结果见表3。Take 2mL 1.00×10 -2 mol/L salicylic acid-ethanol solution, 2mL 9.00×10 -3 mol/L FeSO 4 solution and sample solution into a test tube, then add 2mL 8.8×10 -2 mol/L H 2 O 2 solution, shake well and place in a 37℃ water bath to react for 30min, measure the absorbance A i at 510nm; use 2mL pure water instead of salicylic acid solution to measure the absorbance A j ; use 2mL pure water instead of sample solution to measure the absorbance A 0. Calculate the OH clearance rate (%) according to the formula. Vitamin C was used as the control group. The results are shown in Table 3.
·OH的清除率(%)=[1-(Ai-Aj)/A0]×100%OH removal rate (%) = [1-(A i -A j )/A 0 ] × 100%
表3table 3
由上表可知,本发明实施例1-3制得的淡斑美白精华液具有较好的抗氧化活性。It can be seen from the above table that the spot-lightening and whitening essences prepared in Examples 1-3 of the present invention have good antioxidant activity.
测试例4Test Example 4
选择年龄32-45岁,符合受试者志愿入选标准的志愿者,随机分为实施例1-5、对比例1-14组、空白组,每组10人。Volunteers aged 32-45 years old who met the voluntary inclusion criteria were selected and randomly divided into Example 1-5, Comparative Example 1-14 group and blank group, with 10 people in each group.
实验样品:Experimental samples:
实验组使用实施例1-5或对比例1-14制得的淡斑美白精华液。空白组使用等量的清水。The experimental group used the spot-lightening and whitening essence prepared in Examples 1-5 or Comparative Examples 1-14, and the blank group used an equal amount of water.
测试条件:测试当天受试者用指定洁面样品清洁面部,在温度(25±1)℃,湿度45%±5% RH的实验室中静坐30min。Test conditions: On the test day, the subjects cleaned their faces with the designated cleansing samples and sat quietly in a laboratory with a temperature of (25±1)°C and a humidity of 45%±5% RH for 30 minutes.
实验方法:受试者涂抹样品前,先将试验部位洗净,晾干后涂抹样品。以5×5cm大小的面积作为受试区域;受试者每天早晚在实验区域使用样品两次,实验期间,受试者在实验部位不能涂抹任何其他化妆品。受试者在连续使用样品在第0和第4周测试一次,同一时间将涂抹部位洗净,由Mexameter MX18测试仪和MicroSkin II多功能皮肤镜图像分析系统测定涂抹部位的黑色素含量,每点测五次,取平均值。结果见表4。Experimental method: Before applying the sample, the subjects should wash the test area and apply the sample after drying. An area of 5×5cm was used as the test area; the subjects used the sample twice a day in the morning and evening on the test area. During the experiment, the subjects could not apply any other cosmetics on the test area. The subjects were tested once in the 0th and 4th weeks after continuous use of the sample. At the same time, the application area was washed and the melanin content of the application area was measured by the Mexameter MX18 tester and the MicroSkin II multifunctional dermatoscope image analysis system. Each point was measured five times and the average value was taken. The results are shown in Table 4.
黑色素降低率(%)(末次黑色素含量-首次黑色素含量)/首次黑色素含量×100%Melanin reduction rate (%) (last melanin content - first melanin content) / first melanin content × 100%
相对黑色素降低率(%)=样品组黑色素降低率(%)-空白组黑色素降低率(%)表4Relative melanin reduction rate (%) = sample group melanin reduction rate (%) - blank group melanin reduction rate (%) Table 4
由上表可知,本发明实施例1-3制得的淡斑美白精华液具有较好的美白效果。It can be seen from the above table that the spot-lightening and whitening essences prepared in Examples 1-3 of the present invention have good whitening effects.
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410402420.6A CN118286096A (en) | 2024-04-03 | 2024-04-03 | Freckle-removing and whitening essence and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410402420.6A CN118286096A (en) | 2024-04-03 | 2024-04-03 | Freckle-removing and whitening essence and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118286096A true CN118286096A (en) | 2024-07-05 |
Family
ID=91680784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410402420.6A Pending CN118286096A (en) | 2024-04-03 | 2024-04-03 | Freckle-removing and whitening essence and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118286096A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117982390A (en) * | 2024-02-08 | 2024-05-07 | 广州博科化妆品有限公司 | Preparation method of whitening and anti-freckle cream containing plant essence composite ingredients and hirudin |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006069972A (en) * | 2004-09-02 | 2006-03-16 | Yukihiro Hirose | Skin-whitening composition and cosmetic including the same |
KR100862957B1 (en) * | 2007-04-03 | 2008-10-13 | 바이오스펙트럼 주식회사 | Composition for improving skin wrinkles comprising hyperin as an active ingredient |
CN106852789A (en) * | 2016-12-06 | 2017-06-16 | 长沙协浩吉生物工程有限公司 | A kind of compound method of anti-aging Essence |
CN107854326A (en) * | 2017-12-19 | 2018-03-30 | 乳山寰海生物科技有限公司 | A kind of hirudin moistens face moisturizing maintenance Essence |
CN110731929A (en) * | 2019-08-21 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Mixed birch juice and its application in skin care cosmetic composition |
CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
CN111603428A (en) * | 2020-06-04 | 2020-09-01 | 陶兴仲 | Whitening and freckle-removing plant type essence, preparation method and use method |
-
2024
- 2024-04-03 CN CN202410402420.6A patent/CN118286096A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006069972A (en) * | 2004-09-02 | 2006-03-16 | Yukihiro Hirose | Skin-whitening composition and cosmetic including the same |
KR100862957B1 (en) * | 2007-04-03 | 2008-10-13 | 바이오스펙트럼 주식회사 | Composition for improving skin wrinkles comprising hyperin as an active ingredient |
CN106852789A (en) * | 2016-12-06 | 2017-06-16 | 长沙协浩吉生物工程有限公司 | A kind of compound method of anti-aging Essence |
CN107854326A (en) * | 2017-12-19 | 2018-03-30 | 乳山寰海生物科技有限公司 | A kind of hirudin moistens face moisturizing maintenance Essence |
CN110731929A (en) * | 2019-08-21 | 2020-01-31 | 浙江养生堂天然药物研究所有限公司 | Mixed birch juice and its application in skin care cosmetic composition |
CN111297788A (en) * | 2020-04-24 | 2020-06-19 | 广州名门闺秀生物科技有限责任公司 | Whitening and spot-fading essence and preparation method thereof |
CN111603428A (en) * | 2020-06-04 | 2020-09-01 | 陶兴仲 | Whitening and freckle-removing plant type essence, preparation method and use method |
Non-Patent Citations (1)
Title |
---|
张金宏,等: "苹果渣中结合酚不同提取方法的研究", 食品工业科技, vol. 37, no. 20, 31 December 2016 (2016-12-31), pages 160 - 165 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117982390A (en) * | 2024-02-08 | 2024-05-07 | 广州博科化妆品有限公司 | Preparation method of whitening and anti-freckle cream containing plant essence composite ingredients and hirudin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108567912B (en) | Traditional Chinese medicine extract and enzymolysis and fermentation product thereof | |
KR101041403B1 (en) | Antioxidant and whitening cosmetic composition | |
US8545905B2 (en) | Whitening cosmetic composition containing green tea extract | |
KR100997441B1 (en) | Method for preparing high purity ginsenoside rd using lactobacillus casei and cosmetic composition for anti-wrinkle comprising the high purity ginsenoside rd | |
CN112933011B (en) | Whitening composition and preparation process and application thereof | |
CN115054530B (en) | Skin care composition with moisturizing and anti-aging effects and preparation method thereof | |
CN114588061A (en) | Anti-aging and wrinkle-removing composition, preparation method thereof and skin care product | |
CN116807952A (en) | Active composition extracted from plant and its preparation method | |
KR101375137B1 (en) | A cosmetic composition comprising fermented extract of Scutellaria baicalensis using Leatiporus sulphureus var. miniatus for skin moisturizing | |
CN108703908B (en) | Anti-acne and freckle-removing essence and preparation method thereof | |
CN118286096A (en) | Freckle-removing and whitening essence and preparation method thereof | |
CN118384053A (en) | Anti-hair loss nourishing essence containing hirudin and preparation method and application thereof | |
KR100727743B1 (en) | Skin moisturizing composition containing camphorol as an active ingredient, skin barrier function enhancement, and skin external cosmetic composition for inducing differentiation of keratinocytes | |
CN108852969B (en) | Anti-wrinkle anti-aging whitening mask and preparation method thereof | |
JP3435181B2 (en) | External preparation for melanin production suppression | |
KR100889604B1 (en) | Whitening cosmetics | |
KR20100006796A (en) | Anti-aging cosmetic composition comprising herb ferment extract | |
CN113730292A (en) | Whitening essence and preparation method and application thereof | |
CN117338626B (en) | Anti-aging whitening and moisturizing composition and preparation method thereof | |
KR102350857B1 (en) | Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water | |
CN116617137B (en) | Ginseng seed extract and preparation method thereof | |
KR102327435B1 (en) | Culture broth of Porostereum sp.(KCTC18837P) and Cosmetic composition comprising the same for improving skin condition | |
CN113274329A (en) | Plant whitening extract and application thereof in whitening cosmetics | |
CN118319830B (en) | Skin tightening and anti-wrinkle essence and preparation method thereof | |
KR20230125655A (en) | Method for preparing ferment extract of Eremochloa ophiuroides, ferment extract of Eremochloa ophiuroides and complex functional cosmetic composition comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20241025 Address after: 510000, No. 30 Xinke Kejia North Street, Jiahe Street, Baiyun District, Guangzhou City, Guangdong Province Applicant after: GUANGZHOU B&C COSMETICS Co.,Ltd. Country or region after: China Address before: 510000 No. 45 Fengxiang South Road, Jianggao Town, Baiyun District, Guangzhou City, Guangdong Province Applicant before: GUANGZHOU BIOTECHNOLOGY & COSMETICS Co.,Ltd. Country or region before: China |